The DOI matches its Crossref record; 48 of the 50 references it cites were found in a registry or an index.
Association Between A2a Receptor Gene Polymorphisms and Caffeine-Induced Anxiety
Abstract
The adenosine receptor system, which mediates the psychoactive effects of caffeine, is also thought to be involved in the regulation of anxiety. In this study, we examined the association between variations in anxiogenic responses to caffeine and polymorphisms in the A1 and A2a adenosine receptor genes. Healthy, infrequent caffeine users (N=94) recorded their subjective mood states following a 150 mg oral dose of caffeine freebase or placebo in a double-blind study. We found a significant association between self-reported anxiety after caffeine administration and two linked polymorphisms on the A2a receptor gene, the 1976C>T and 2592C>Tins polymorphisms. Individuals with the 1976T/T and the 2592Tins/Tins genotypes reported greater increases in anxiety after caffeine administration than the other genotypic groups. The study shows that an adenosine receptor gene polymorphism that has been associated with Panic Disorder is also associated with anxiogenic responses to an acute dose of caffeine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, common variants of the gene encoding for the A2a receptor can disrupt sleep (51) or cause anxiety in some individuals (52) after ingesting caffeine.”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [52]
Citations
Cites
McNair, D. M. (1992) · Medical Entomology and Zoology · Cited by 2,527
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
den Dunnen, J. T., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1 · Cited by 1,757
The Measurement and Appraisal of Adult Intelligence (4th ed.).
Wechsler, D. (1958) · doi:10.1037/11167-000 · Cited by 1,683
A Shortened Version of the Profile of Mood States
Shacham, S. (1983) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4703_14 · Cited by 1,231 · cited 7×
“Genetic variation in caffeine-induced anxiety K Alsene et al segment overlap at a pairwise score cutoff of 60.”
BackgroundInfluentialA workbench for multiple alignment construction and analysis
Schuler, G. D., Altschul, S. F., & Lipman, D. J. (1991) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340090304 · Cited by 985
Martin, W. R., Sloan, J. W., SAPIRA, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 945
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C. A., Vaugeois, J., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J. J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Structure and function of adenosine receptors and their genes
Fredholm, B. B., Arslan, G., Halldner, L., Kull, B., Schulte, G., & Wasserman, W. W. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000313 · Cited by 583
Research advances in alcohol and drug problems
Stephenson, J. P. (1975) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(75)90081-1 · Cited by 575
Johansson, B. A., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez‐Llort, L., Escorihuela, R. M., Fernández‐Teruel, A., Wiesenfeld‐Hallin, Z., Xu, X.-J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161292398 · Cited by 506
Research works printed but not linked: 2
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Text Revised. American Psychiatric Association: Washington, DC.
- Deckert J, Kuhlenbäumer G, Weiß K, Schirmacher A, Ringelstein EB, Arolt V et al (2001). Chromosome 22q11.2 as a candidate gene locus: association of the more active COMT-allele with panic disorder. Am J Med Genet 105: 570.
Cited by
Sorted by citations
Fifty years of the Barratt Impulsiveness Scale: an update and review
Stanford, M. S., Mathias, C. W., Dougherty, D. M., Lake, S. L., Anderson, N. E., & Patton, J. H. (2009) · Personality and Individual Differences · doi:10.1016/j.paid.2009.04.008 · Cited by 1,609
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J. M., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,307
Sleep Deprivation and Vigilant Attention
Lim, J., & Dinges, D. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.002 · Cited by 1,213
Caffeinated energy drinks a growing problem
Reissig, C. J., Strain, E. C., & Griffiths, R. R. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.001 · Cited by 1,026
Adenosine receptors as drug targets — what are the challenges?
Chen, J., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 923
Fredholm, B. B., Chen, J., Cunha, R. A., Svenningsson, P., & Vaugeois, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63007-3 · Cited by 721
International society of sports nutrition position stand: caffeine and performance
Goldstein, E. R., Ziegenfuss, T., Kalman, D., Kreider, R., Campbell, B., Wilborn, C., Taylor, L., Willoughby, D., Stout, J., Graves, B. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-5 · Cited by 686
International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance
Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632
Scientific Opinion on the safety of caffeine
EFSA Panel on Dietetic Products, N. A. A. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4102 · Cited by 613
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 613
Ribeiro, J. A., & Sebastião, A. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1379 · Cited by 584
The Safety of Ingested Caffeine: A Comprehensive Review
Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557
Clark, I., & Landolt, H. P. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.01.006 · Cited by 499
Comorbidity of insomnia and depression
Staner, L. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.09.003 · Cited by 481
The Effect of Exercise Training on Anxiety Symptoms Among Patients: A Systematic Review
Herring, M. P. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.530 · Cited by 446
Wikoff, D. S., Welsh, B. T., Henderson, R. G., Brorby, G. P., Britt, J. K., Myers, E. F., Goldberger, J. J., Lieberman, H. R., O’Brien, C. P., Peck, J. D., et al. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.04.002 · Cited by 470
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illés, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 402
ACTIONS OF ADENOSINE AT ITS RECEPTORS IN THE CNS: Insights from Knockouts and Drugs
Fredholm, B. B., Chen, J., Masino, S. A., & Vaugeois, J. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095731 · Cited by 365
Caffeine use in children: What we know, what we have left to learn, and why we should worry
Temple, J. L. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.01.001 · Cited by 335
Genetics of caffeine consumption and responses to caffeine
Yang, A., Palmer, A. A., & de Wit, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1900-1 · Cited by 330
Rétey, J. V., Adam, M., Khatami, R., Luhmann, U. F. O., Jung, H. H., Berger, W., & Landolt, H.-P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100102 · Cited by 278
Adenosine Receptors and the Central Nervous System
Sebastião, A. M., & Ribeiro, J. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_16 · Cited by 271
Hayes, J. E., Wallace, M. R., Knopik, V. S., Herbstman, D. M., Bartoshuk, L. M., & Duffy, V. B. (2010) · Chemical Senses · doi:10.1093/chemse/bjq132 · Cited by 261
Rétey, J., Adam, M., Honegger, E., Khatami, R., Luhmann, U. F. O., Jung, H. H., Berger, W., & Landolt, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505414102 · Cited by 260
Roy‐Byrne, P., Craske, M. G., & Stein, M. B. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69418-x · Cited by 277
Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
Childs, E., Hohoff, C., Deckert, J., Xu, K., Badner, J. A., & de Wit, H. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.17 · Cited by 252
Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation
James, J. E., & Rogers, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0084-6 · Cited by 231
Caffeine, Mental Health, and Psychiatric Disorders
Lara, D. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1378 · Cited by 245
Cunha, R. A., & Agostinho, P. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1408 · Cited by 241
Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption
Cornelis, M. C., El‐Sohemy, A., & Campos, H. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.1.240 · Cited by 231
The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate?
Addicott, M. A., Yang, L. L., Peiffer, A. M., Burnett, L. R., Burdette, J. H., Chen, M. Y., Hayasaka, S., Kraft, R. A., Maldjian, J. A., & Laurienti, P. J. (2009) · Human Brain Mapping · doi:10.1002/hbm.20732 · Cited by 210
Rogers, P. J., Hohoff, C., Heatherley, S. V., Mullings, E. L., Maxfield, P. J., Evershed, R. P., Deckert, J., & Nutt, D. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.71 · Cited by 212
Self-citationCaffeine Use Disorder: A Comprehensive Review and Research Agenda
Meredith, S. E., Juliano, L. M., Hughes, J. R., & Griffiths, R. R. (2013) · Journal of Caffeine Research · doi:10.1089/jcr.2013.0016 · Cited by 230
Pickering, C., & Kiely, J. (2017) · Sports Medicine · doi:10.1007/s40279-017-0776-1 · Cited by 228
Caffeine and the dopaminergic system
Cauli, O., & Morelli, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00001 · Cited by 196
Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Cunha, R. A., Ferré, S., Vaugeois, J., & Chen, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480090 · Cited by 195
Monteiro, J., Alves, M. G., Oliveira, P. F., & Silva, B. M. (2016) · Molecules · doi:10.3390/molecules21080974 · Cited by 195
Adenosine, caffeine, and sleep–wake regulation: state of the science and perspectives
Reichert, C. F., Deboer, T., & Landolt, H. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13597 · Cited by 183
“Moreover, healthy people with polymorphisms in the ADORA2A gene exhibit elevated risk of anxiety symptoms when consuming normal amounts of caffeine-containing products (Alsene et al., 2003).”
BackgroundRogers, P. J., Smith, J. E., Heatherley, S. V., & Pleydell-Pearce, C. W. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0938-1 · Cited by 183
Do initial responses to drugs predict future use or abuse?
de Wit, H., & Phillips, T. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.04.005 · Cited by 172
Gonçalves, L. D. S., Painelli, V. D. S., Yamaguchi, G., Oliveira, L. F. D., Saunders, B., da Silva, R. P., Maciel, E., Artioli, G. G., Roschel, H., & Gualano, B. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00260.2017 · Cited by 173
Caffeine and Exercise: What Next?
Pickering, C., & Grgić, J. (2019) · Sports Medicine · doi:10.1007/s40279-019-01101-0 · Cited by 195
Bandelow, B., Baldwin, D. S., Abelli, M., Altamura, C. A., Dell’Osso, B. M., Domschke, K., Fineberg, N. A., Grünblatt, E., Jarema, M., Maron, E., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1181783 · Cited by 174
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
IJzerman, A. P., Jacobson, K. A., Müller, C. E., Cronstein, B. N., & Cunha, R. A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000445 · Cited by 169
The effect of caffeine on energy balance
Harpaz, E., Tamir, S., Weinstein, A., & Weinstein, Y. (2016) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2016-0090 · Cited by 161
Ullrich (2018) · doi:10.1038/mp.2017.188 · Cited by 145
Wei, C. J., Li, W., & Chen, J. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.018 · Cited by 153
Evidence for Genetic Linkage Between a Polymorphism in the Adenosine 2A Receptor and Panic Disorder
Hamilton, S. P., Slager, S. L., Baisre, A., Heiman, G. A., Klein, D. F., Hodge, S. E., Weissman, M. M., Fyer, A. J., & Knowles, J. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300311 · Cited by 147
The role of adenosine receptors in mood and anxiety disorders
van Calker, D., Biber, K. P. H., Domschke, K., & Serchov, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14841 · Cited by 146
Mitchell, E. S., Slettenaar, M., Meer, N. V., Transler, C., Jans, L. A. W., Quadt, F., & Berry, M. J. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.07.027 · Cited by 127
Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics
Ortiz, R., Ulrich, H., Zarate, C. A., & Machado‐Vieira, R. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.10.016 · Cited by 129
Thorn, C. F., Aklillu, E., McDonagh, E. M., Klein, T. E., & Altman, R. B. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283505d5e · Cited by 124
Imaging genetics of anxiety disorders
Domschke, K., & Dannlowski, U. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.042 · Cited by 127
Neuropsychiatric effects of caffeine
Winston, A. P., Hardwick, E., & Jaberi, N. (2005) · Advances in Psychiatric Treatment · doi:10.1192/apt.11.6.432 · Cited by 120
Adenosine receptor neurobiology: overview
Chen, J.-F., Lee, C.-F., & Chern, Y. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00001-5 · Cited by 119
Rétey, J., Adam, M., Gottselig, J. M., Khatami, R., Dürr, R., Achermann, P., & Landolt, H. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1538-06.2006 · Cited by 117
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s disease
Popat, R. A., Eeden, S. K. V. D., Tanner, C. M., Kamel, F., Umbach, D. M., Marder, K. S., Mayeux, R. P., Ritz, B. R., Ross, G. W., Petrovitch, H., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03353.x · Cited by 119
Bodenmann, S., Hohoff, C., Freitag, C. M., Deckert, J., Rétey, J., Bachmann, V., & Landolt, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01689.x · Cited by 125
Life events in panic disorder-an update on “candidate stressors”
Klauke, B., Deckert, J., Reif, A., Pauli, P., & Domschke, K. (2010) · Depression and Anxiety · doi:10.1002/da.20667 · Cited by 127
Early effects of caffeinated and decaffeinated coffee on subjective state and gender differences
Adan, A., Prat, G., Fabbri, M., & Sànchez-Turet, M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.005 · Cited by 113
Adenosine, Caffeine, and Performance: From Cognitive Neuroscience of Sleep to Sleep Pharmacogenetics
Urry, E., & Landolt, H. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_274 · Cited by 117
Advances in molecular genetics of panic disorder
Maron, E., Hettema, J. M., & Shlik, J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.145 · Cited by 111
Martin, V. T., & Vij, B. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12953 · Cited by 113
Psychopharmacology of theobromine in healthy volunteers
Baggott, M. J., Childs, E., Hart, A. B., de Bruin, E. A., Palmer, A. A., Wilkinson, J. E., & de Wit, H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3021-0 · Cited by 106
Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety
Coelho, J. E., Alves, P., Canas, P. M., Valadas, J. S., Shmidt, T., Batalha, V. L., Ferreira, D. G., Ribeiro, J. A., Bader, M., Cunha, R. A., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00067 · Cited by 102
Hohoff, C., Mullings, E. L., Heatherley, S. V., Freitag, C. M., Neumann, L. C., Domschke, K., Krakowitzky, P., Rothermundt, M., Keck, M. E., Erhardt, A., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.006 · Cited by 104
Low, but not high, dose caffeine is a readily available probe for adenosine actions
Fredholm, B. B., Yang, J., & Wang, Y.-Q. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.11.011 · Cited by 99
Pharmacological potential of methylxanthines: Retrospective analysis and future expectations
Monteiro, J., Alves, M. G., Oliveira, P. F., & Silva, B. M. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1461607 · Cited by 104
Prediger, R. D., Silva, G. E. D., Batista, L. C., Bittencourt, A. L., & Takahashi, R. N. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301001 · Cited by 97
Haskell‐Ramsay, C. F., Jackson, P. A., Forster, J. S., Dodd, F. L., Bowerbank, S. L., & Kennedy, D. O. (2018) · Nutrients · doi:10.3390/nu10101386 · Cited by 104
Multi-ingredient, Caffeine-containing Dietary Supplements: History, Safety, and Efficacy
Gurley, B. J., Steelman, S. C., & Thomas, S. L. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.08.012 · Cited by 96
Involvement of Adenosine A2A Receptors in Depression and Anxiety
Yamada, K., Kobayashi, M., & Kanda, T. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00015-5 · Cited by 94
The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective
Rao, T., Tan, Z., Peng, J., Guo, Y., Chen, Y., Zhou, H., & Ouyang, D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104283 · Cited by 94
Lazarus, M., Chen, J., Huang, Z., Urade, Y., & Fredholm, B. B. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_36 · Cited by 100
Wilk, M., Krzysztofik, M., Filip-Stachnik, A., Zając, A., & Coso, J. D. (2019) · Nutrients · doi:10.3390/nu11081912 · Cited by 98
Doepker, C., Lieberman, H. R., Smith, A. P., Peck, J. D., El-Sohemy, A., & Welsh, B. T. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033243 · Cited by 87
Adenosine and Related Drugs in Brain Diseases: Present and Future in Clinical Trials
Lopes, L. V., Sebastião, A. M., & Ribeiro, J. A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347591 · Cited by 88
Caffeine and Exercise Performance: Possible Directions for Definitive Findings
Martins, G. L., Guilherme, J. P. L. F., Ferreira, L. H. B., de Souza, T. P., & Lancha, A. H. (2020) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2020.574854 · Cited by 95
Salinero, J. J., Lara, B., Ruiz-Vicente, D., Areces, F., Puente, C., Gallo–Salazar, C., Pascual, T., & Coso, J. D. (2017) · Nutrients · doi:10.3390/nu9030269 · Cited by 87
The Role of Genetics in Moderating the Inter-Individual Differences in the Ergogenicity of Caffeine
Southward, K., Rutherfurd-Markwick, K., Badenhorst, C., & Ali, A. (2018) · Nutrients · doi:10.3390/nu10101352 · Cited by 81
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
Dhaenens, C., Burnouf, S., Simonin, C., Brussel, E. V., Duhamel, A., Defebvre, L., Duru, C., Vuillaume, I., Cazeneuve, C., Charles, P., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.009 · Cited by 82
Freitag, C. M., Agelopoulos, K., Huy, E., Rothermundt, M., Krakowitzky, P., Meyer, J., Deckert, J., von Gontard, A., & Hohoff, C. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0043-6 · Cited by 75
ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus
Shinohara, M., Saitoh, M., Nishizawa, D., Ikeda, K., Hirose, S., Takanashi, J., Takita, J., Kikuchi, K., Kubota, M., Yamanaka, G., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f18d8 · Cited by 75
Arnold, P. D., Zai, G. C., & Richter, M. A. (2004) · Current Psychiatry Reports · doi:10.1007/s11920-004-0073-1 · Cited by 74
Kennedy, D. O., & Haskell, C. F. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2010.12.010 · Cited by 73
Adenosine A 1 , but not A 2 , Receptor Blockade Increases Anxiety and Arousal in Zebrafish
Maximino, C., Lima, M. G., Olivera, K. R. M., Picanço-Diniz, D. L. W., & Herculano, A. M. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00710.x · Cited by 73
Impact of Genetic Variability on Physiological Responses to Caffeine in Humans: A Systematic Review
Fulton, J. L., Dinas, P. C., Carrillo, A. E., Edsall, J. R., Ryan, E. J., & Ryan, E. J. (2018) · Nutrients · doi:10.3390/nu10101373 · Cited by 76
Sharma, S., Das, M., Kumar, A., Marwaha, V., Shankar, S., Singh, P., Raghu, P., Aneja, R., Grover, R., Arya, V., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328331b53e · Cited by 69
Genetic determinants of blood pressure responses to caffeine drinking
Renda, G., Zimarino, M., Antonucci, I., Tatasciore, A., Ruggieri, B., Bucciarelli, T., Prontera, T., Stuppia, L., & Caterina, R. D. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.018267 · Cited by 69
Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders
Domenici, M. R., Ferrante, A., Martire, A., Chiodi, V., Pepponi, R., Tebano, M. T., & Popoli, P. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104338 · Cited by 74
The type 1 equilibrative nucleoside transporter regulates anxiety‐like behavior in mice
Chen, J., Rinaldo, L., Lim, S. ‐., Young, H., Messing, R. O., & Choi, D. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00311.x · Cited by 68
Genetic determination of sleep EEG profiles in healthy humans
Landolt, H.-P. (2011) · Progress in Brain Research · doi:10.1016/b978-0-444-53839-0.00004-1 · Cited by 67
Blood Pressure in Relation to Coffee and Caffeine Consumption
Guessous, I., Eap, C. B., & Bochud, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0468-2 · Cited by 69
Caffeine intake and anxiety: a meta-analysis
Liu, C., Wang, L., Zhang, C., Hu, Z., Tang, J., Xue, J., & Lu, W. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1270246 · Cited by 80
Adenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition
Shen, H., & Chen, J. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152191 · Cited by 67
Klevebrant, L., & Frick, A. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2021.11.005 · Cited by 80
Genotype-Dependent Differences in Sleep, Vigilance, and Response to Stimulants
Landolt, H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549344 · Cited by 66
Storm in a coffee cup: caffeine modifies brain activation to social signals of threat
Smith, J. E., Lawrence, A. D., Diukova, A., Wise, R. G., & Rogers, P. J. (2011) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsr058 · Cited by 62
Metadata
- Authors
- Alsene, K., Deckert, J., Sand, P., & de Wit, H.
- Affiliations
- University of Chicago (US)
- University of Münster (DE)
- University of Würzburg (DE)
- Venue
- Neuropsychopharmacology
- Published
- 2003-05-14
- Volume
- 28
- Issue
- 9
- Pages
- 1694-1702
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2043153453
- Cited by
- 334
- References
- 50
- Citations by year
- 2026: 12 · 2025: 6 · 2024: 10 · 2023: 12 · 2022: 8 · 2021: 13 · 2020: 13 · 2019: 18 · 2018: 18 · 2017: 16 · 2016: 19 · 2015: 9 · 2014: 21 · 2013: 11 · 2012: 21
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 02812, R01DA002812)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Keywords
- caffeine, anxiety, adenosine A2A receptor, adenosine A1 receptor, genetic polymorphism, subjective mood, panic disorder, genetic susceptibility
- MeSH terms
- Adult, Central Nervous System Stimulants, Animals, Anxiety, Caffeine, Cysteine, Double-Blind Method, Female, Genotype, Humans, Hybrid Vigor, Male, Neuropsychological Tests, Pain Measurement, Personality Inventory, Polymorphism, Genetic, Threonine, Time Factors, Genetic Variation, Sequence Analysis, DNA, Receptors, Purinergic P1, Tandem Repeat Sequences, Receptor, Adenosine A2A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review